Molekule develops Photo Electrochemical Oxidation (PECO) air purification devices, including the Air Mini, Air Mini+ and Air Pro. Its PECO technology is designed to destroy VOCs, mold, bacteria, viruses and allergens. The Air Mini, Air Mini+ and Air Pro were recently granted FDA clearance as medical devices for the destruction of viruses and bacteria. Molekule sells directly at Molekule.com, on Amazon and through other retailers, and its products are available internationally in India, Japan, South Korea and Canada. The company said it will use new investment funds to advance its air quality technology and expand its business reach. Led by CEO Jonathan Harris, Molekule had raised more than $100m prior to this deal, most recently via a Series C completed in early 2020. Molekule's core product is its patented PECO technology, which it says oxidizes and destroys a wide range of tiny airborne pollutants, including viruses, bacteria, VOCs, formaldehyde and ozone. The company cites more than 20 years of research and says PECO has been validated by third-party laboratories and internal testing. Molekule's products meet applicable performance criteria recommended by U.S. FDA guidance for use in helping reduce the risk of exposure to SARS-CoV-2 in healthcare settings during the COVID-19 public health emergency. The company is pursuing global expansion and has entered the Japanese market through a distribution and partnership agreement. As part of that agreement, Sourcenext invested $10 million to be used for growth initiatives as Molekule prepares to meet strong international demand. Molekule positions its hardware and software offerings together with its patented filter technology as a differentiated approach to indoor air purification. Molekule develops air-purification devices that use PECO light-driven chemistry to break down volatile organic compounds, mold and bacteria rather than relying solely on particulate capture. The company traces its technology to research by Dr. Yogi Goswami and is led by co-founder and CEO Jaya Rao. Molekule has faced mixed independent test results—Berkeley Lab and Intertek tests reported removal of VOCs and no harmful byproducts, while Wirecutter and Consumer Reports found weaker particulate capture versus HEPA units. The company has expanded its product line with a mini unit for smaller rooms and is pushing into commercial verticals such as hotels and hospitals. Molekule reports a 3x year-over-year increase in filter subscription revenue since launch and roughly 200% repeat customer growth. Despite negative press, it continues to emphasize third-party validation and peer-reviewed research behind PECO. Molekule develops air purification devices that use a patented Photo Electrochemical Oxidation (PECO) process to break down pollutants at a molecular level. Its technology, developed by Dr. Yogi Goswami, targets bacteria, mold, toxic gasses (VOCs), dust, smoke and other airborne allergens. The company plans to expand its product line, scale manufacturing and grow the team. Molekule is led by CEO Dilip Goswami and was founded in 2014. It employs about 80 people and ships to the United States, Alaska, Hawaii, Puerto Rico, the U.S. Virgin Islands and Canada. The company closed a $25M Series B to support its growth plans. Molekule makes a molecular air purifier that uses Photo Electrochemical Oxidation (PECO) nanotechnology to combat and destroy allergens, mold, bacteria and airborne chemicals at a molecular level. The device can completely purify and replace the air in a 600 square foot room without the use of a high-powered fan, making it energy efficient and ultra quiet. It connects to Wi‑Fi, uses machine learning to respond to the individual needs of each household, and can be controlled via an iPhone app. Molekule retails the device at $799 and offers annual filter subscriptions for $99. The company announced the device’s availability to the general public. Molekule intends to use new funding to scale production, expand its team and build out its product pipeline.

Total raised

$106M

Funding rounds

6

Latest round

Equity

Latest activity

Sep 2020